Anna Geiger
@annageiger.bsky.social
Operations Coordinator @ The Institute for Clinical & Economic Review | Cognitive Psychology Research Assistant @ Northeastern University
Reposted by Anna Geiger
Institute for Clinical and Economic Review Publishes Evidence Report on Treatment for Acute Pain: icer.org/news-insight...
Institute for Clinical and Economic Review Publishes Evidence Report on Treatment for Acute Pain - ICER
Current evidence suggests that suzetrigine may provide a net health benefit when compared to no systemic treatment, opioid analgesics, and NSAIDs; at expected pricing, treatment is likely to be cost-e...
icer.org
February 5, 2025 at 9:34 PM
Institute for Clinical and Economic Review Publishes Evidence Report on Treatment for Acute Pain: icer.org/news-insight...
Reposted by Anna Geiger
Vertex prices suzetrigine (Journavx) at $31/day. ICER’s report finds it cost-saving.
Better than placebo in trials but that doesn’t mean much.
Similar effect to 5 mg oxy/325 mg tylenol for tummy tuck but slower for bunionectomy. Sample size very small. www.technologynetworks.com/tn/news/us-a...
Better than placebo in trials but that doesn’t mean much.
Similar effect to 5 mg oxy/325 mg tylenol for tummy tuck but slower for bunionectomy. Sample size very small. www.technologynetworks.com/tn/news/us-a...
US Approves Non-Opioid Painkiller: What Is It, and How Does It Work?
The US Food and Drug Administration (FDA) announced its approval of a non-opioid treatment for moderate–severe acute chronic pain. The drug, Journavx™ (suzetrigine), represents the first new class of ...
www.technologynetworks.com
January 31, 2025 at 2:05 PM
Vertex prices suzetrigine (Journavx) at $31/day. ICER’s report finds it cost-saving.
Better than placebo in trials but that doesn’t mean much.
Similar effect to 5 mg oxy/325 mg tylenol for tummy tuck but slower for bunionectomy. Sample size very small. www.technologynetworks.com/tn/news/us-a...
Better than placebo in trials but that doesn’t mean much.
Similar effect to 5 mg oxy/325 mg tylenol for tummy tuck but slower for bunionectomy. Sample size very small. www.technologynetworks.com/tn/news/us-a...
Reposted by Anna Geiger
On Thursday, the US Food and Drug Administration approved suzetrigine for short-term pain management, making it the first non-opioid pain drug given a regulatory nod in more than 20 years.
https://go.nature.com/40SKITt
https://go.nature.com/40SKITt
US drug agency approves potent painkiller — the first non-opioid in decades
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
go.nature.com
January 31, 2025 at 9:00 AM
On Thursday, the US Food and Drug Administration approved suzetrigine for short-term pain management, making it the first non-opioid pain drug given a regulatory nod in more than 20 years.
https://go.nature.com/40SKITt
https://go.nature.com/40SKITt
Reposted by Anna Geiger
Institute for Clinical and Economic Review to Assess Treatments for Spinal Muscular Atrophy: tinyurl.com/vn98zuvh
Institute for Clinical and Economic Review to Assess Treatments for Spinal Muscular Atrophy - ICER
Report will be subject of Midwest CEPAC meeting in August 2025; Draft Scoping Document open to public comment until January 27, 2025.
tinyurl.com
January 6, 2025 at 12:56 PM
Institute for Clinical and Economic Review to Assess Treatments for Spinal Muscular Atrophy: tinyurl.com/vn98zuvh